Wikisage, the free encyclopedia of the second generation, is digital heritage
Mepolizumab
Mepolizumab is a humanized monoclonal antibody to interleukin-5 (IL-5) which leads to a decrease in production and maturation of eosinophils and results in a reduction in allergic symptoms of asthma and hypereosinophilic síndromes [1]
Links
| References: |